Prognostic Value of Soluble Suppression of Tumorigenicity 2 in Chronic Kidney Disease Patients: A Meta-Analysis

Figure 3

Association between sST2 and cardiovascular disease (CVD) mortality in CKD patients: (a) overall analysis; (b) subgroup analysis based on continent (Europe and America vs. Asia).

(a)

(b)